Generic Name and Formulations:
Clindamycin (as phosphate) 1%; foam; contains alcohol.
Indications for EVOCLIN:
Wash and dry skin. Apply once daily. Dispense an amount that will cover the affected area(s) into cap or other cool surface. Pick up a small amount of foam with fingertips and massage into affected area(s) until foam disappears.
History of regional enteritis, ulcerative or antibiotic-associated colitis (including pseudomembranous colitis).
Atopic patients. Discontinue if significant diarrhea, irritation, or dermatitis occurs. Avoid contact with eyes, mouth, lips, other mucous membranes or broken skin. Discontinue if no improvement after 6–8 weeks or if condition worsens. Product is flammable. Pregnancy (Cat.B). Nursing mothers: not recommended.
May potentiate neuromuscular blockers. Cross-resistance may occur with erythromycin. Prolonged and/or worsened severe colitis with antiperistaltic agents (eg, opiates, diphenoxylate with atropine).
Application site reactions (eg, burning, pruritus, dryness), headache, irritation, gram (–) folliculitis, abdominal pain, Gl disturbances; rare: diarrhea, pseudomembranous colitis.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia